PlainRecalls
FDA Devices Moderate Class II Terminated

Novocastr Liquid Mouse Monoclonal Antibody CDX2 (CDX2) is recommended for the assessment of CDX2 protein in normal and neoplastic tissues.

Reported: June 8, 2016 Initiated: April 5, 2016 #Z-1877-2016

Product Description

Novocastr Liquid Mouse Monoclonal Antibody CDX2 (CDX2) is recommended for the assessment of CDX2 protein in normal and neoplastic tissues.

Reason for Recall

Testing of retained units indicated that Lot numbers of CDX2 indicated are not stable up to the expiry date on the product labeling.

Details

Recalling Firm
Leica Microsystems, Inc.
Units Affected
90 Units
Distribution
Distributed in the following states AR, CA, CT, FL, ID, IL, IN, MT, OH, PA, TN and TX, and in Canada.
Location
Buffalo Grove, IL

Frequently Asked Questions

What product was recalled?
Novocastr Liquid Mouse Monoclonal Antibody CDX2 (CDX2) is recommended for the assessment of CDX2 protein in normal and neoplastic tissues.. Recalled by Leica Microsystems, Inc.. Units affected: 90 Units.
Why was this product recalled?
Testing of retained units indicated that Lot numbers of CDX2 indicated are not stable up to the expiry date on the product labeling.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 8, 2016. Severity: Moderate. Recall number: Z-1877-2016.